Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens

NCT02314325 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Severe Haemophilia A

Interventions

DRUG: ADVATE [Antihemophilic Factor (Recombinant)]
DRUG: ADVATE [Antihemophilic Factor (Recombinant)]

Sponsor

St. James's Hospital, Ireland

Collaborators

[object Object]